Trials / Completed
CompletedNCT00569998
Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin
An Open-label, Multi-centre, Multi-national, Comparative, Randomised, Cross-over Trial Evaluating Preference as Well as Performance, Acceptance, Handling and Safety of NovoPen™ 4 (MS236) Versus NovoPen 3® in Insulin Treated Diabetic Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 208 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
This trial is conducted in Europe. The aim of this trial is to compare two insulin delivery pens in the everyday life setting of patients with diabetes treated with insulin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovoPen™ 4 | |
| DEVICE | NovoPen® 3 |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2004-02-01
- Completion
- 2004-02-01
- First posted
- 2007-12-10
- Last updated
- 2017-01-19
Locations
23 sites across 5 countries: Austria, Germany, Italy, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT00569998. Inclusion in this directory is not an endorsement.